SPOTLIGHT: Sciele readies six meds for market

Sciele Pharma expects to launch six new products in 2008, executives announced, including a new formulation of its blood pressure drug Sular and two forms of the Prandin drug for Type II diabetes, plus at least two meds awaiting FDA approval. Release

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.